• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-45
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Paralysis (1997)
Event Date 07/24/2023
Event Type  Injury  
Event Description
It was reported that the patient underwent a deep brain stimulation (dbs) stage one lead implant procedure.The procedure was successful, and the scans did not show any bleeding.Two days later the patient was instructed by his cardiologist to re-start his anticoagulant medication, lovenox.A few days later the patient experienced stroke like symptoms of confusion, paralysis and alertness, and therefore was admitted to the hospital where a hematoma was discovered.The patient underwent a hematoma evacuation procedure, and the left lead and burr hole cover were explanted.The right lead remains implanted and there will be no further course of action regarding the right lead.The physician assessed that the event was not device or procedure related, rather it was due to the patient being instructed to begin taking the lovenox medication too early.Due to the hematoma the patient experienced paralysis and was not conscious.The patient was released from the hospital, and the paralysis has resolved.The patient was at a rehabilitation facility, gaining strength and functions back, and is now at a hospice care facility.The explanted devices will not be returned as they were disposed at the facility.
 
Manufacturer Narrative
Additional suspect medical device components involved in the event: product family dbs-linear leads, upn m365db2202450, model db-2202-45, serial (b)(6), batch 7105092.Product family dbs-lead fixation, upn m354db4600c0, model db4600c, lot 31573515, batch 31573515.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key17571883
MDR Text Key321417090
Report Number3006630150-2023-04879
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905288
UDI-Public08714729905288
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberDB-2202-45
Device Catalogue NumberDB-2202-45
Device Lot Number7107449
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/25/2023
Initial Date FDA Received08/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
Patient Age78 YR
Patient SexMale
-
-